Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

We can also tell you Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. is a…

• …Scholarly work
• …Cited work

If you know more about Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group., you can add more facts here »

Similar topics in Freebase

• The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.

• Can we induce tolerance in rheumatoid arthritis?

• Comparison between fascicular and whole sural nerve biopsy

• Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)

• Shoptaw S, Kintaudi PC, Charuvastra C, Ling W. A screening trial of amantadine as a medication for cocaine dependence. Drug Alcohol Depend. 2002 May 1;66(3):217-24.

• Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06

• Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation

• What is the best perfusion temperature for coronary revascularization?

• Enhanced p24 antigen detection in sera from human immunodeficiency virus-infected children

• Intensive evaluation of referred unclassified neuropathies yields improved diagnosis